4//SEC Filing
French Glendon E. III 4
Accession 0001415889-25-001819
CIK 0001127537other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 5:59 PM ET
Size
6.8 KB
Accession
0001415889-25-001819
Insider Transaction Report
Form 4
Pulmonx CorpLUNG
French Glendon E. III
Director
Transactions
- Sale
Common Stock
2025-01-16$6.53/sh−2,326$15,189→ 1,069,648 total - Sale
Common Stock
2025-01-17$6.50/sh−2,221$14,437→ 1,067,427 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.50 to $6.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Pulmonx Corp
CIK 0001127537
Entity typeother
Related Parties
1- filerCIK 0001805624
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 5:59 PM ET
- Size
- 6.8 KB